- Home
- MKTX vs HIMS Comparison
MKTX vs HIMS Comparison
Compare MKTX & HIMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MKTX | HIMS |
|---|---|---|
| Founded | 2000 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical/Nursing Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 6.8B |
| IPO Year | 2004 | 2019 |
Fundamental Metrics
Financial Performance| Metric | MKTX | HIMS |
|---|---|---|
| Price | $164.68 | $27.63 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 12 | 15 |
| Target Price | ★ $162.22 | $31.15 |
| AVG Volume (30 Days) | 717.2K | ★ 8.1M |
| Earning Date | 10-23-2026 | 11-09-2026 |
| Dividend Yield | ★ 1.90% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.13 | N/A |
| Revenue | $397,471,000.00 | ★ $2,347,637,000.00 |
| Revenue This Year | $5.90 | $36.65 |
| Revenue Next Year | $6.65 | $24.59 |
| P/E Ratio | $39.87 | ★ N/A |
| Revenue Growth | 7.45 | ★ 59.00 |
| 52 Week Low | $108.75 | $13.74 |
| 52 Week High | $195.97 | $50.19 |
Technical Indicators
Market Signals| Indicator | MKTX | HIMS |
|---|---|---|
| Relative Strength Index (RSI) | 71.68 | 43.87 |
| Support Level | $163.18 | $27.14 |
| Resistance Level | $165.87 | $31.35 |
| Average True Range (ATR) | 0.28 | 1.86 |
| MACD | -0.21 | -0.10 |
| Stochastic Oscillator | 55.05 | 23.17 |
Price Performance
Historical ComparisonAbout MKTX MarketAxess Holdings Inc.
Founded in 2000, MarketAxess is a leading electronic fixed-income trading platform that connects broker/dealers and institutional investors. The company is primarily focused on credit based fixed income securities with its main trading products being US investment-grade and high-yield bonds, Eurobonds, and Emerging Market corporate debt. Recently the company has expanded more aggressively into Treasuries and municipal bonds with the acquisitions of LiquidityEdge and MuniBrokers in 2019 and 2021, respectively. The company also provides pre- and post-trade services with its acquisition of Regulatory Reporting Hub from Deutsche Börse Group in 2020 adding to its product offerings.
About HIMS Hims & Hers Health Inc.
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.